Jamjoom Pharmaceuticals Factory Co. (4015)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

16 September 03:00 AM Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a strategic commercialization agreement with Bio-Thera Solutions Limited, a global biopharmaceutical firm specializing in innovative therapies and biosimilars.Unde

Global Economy

1 July 03:00 AM Jamjoom Pharma appoints new Chairman, Vice Chairman

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has named Mahmoud Yousuf Jamjoom as the board’s Chairman for the next three years.The board also announced Ahmed Yousuf Jamjoom as the Vice Chairman, according to a bourse di

Board of Directors

30 April 03:00 AM Jamjoom Pharma logs SAR 157m net profits in Q1-25

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits amounting to SAR 157.03 million in the first quarter (Q1) of 2025, an annual growth of 52.50% from SAR 102.97 million.Revenues soared by 18.69% to SAR 45

Sector Reports

25 February 08:42 PM Jamjoom Pharma registers 22% higher profits backed by expansion in Egypt

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted 21.93% higher net profits at SAR 356.52 million in 2024, compared to SAR 292.40 million in 2023. Revenues jumped by 19.77% year-on-year (YoY) to SAR 1.31 billion as …

Financial Results

15 January 03:28 PM Jamjoom Pharma partakes in 43rd J.P. Morgan Healthcare Conference 2025

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) is participating in the 43rd Annual J.P. Morgan Healthcare Conference that is taking place in the US, according to a press release. The conference is being held on 13-16 …

Companies Investments

5 January 10:09 PM TASI expected to trade between 11,300 to 13,300pts in 2025 – Report

Riyadh – Mubasher: SNB Capital, a regional financial institution, recently projected in a report that the benchmark All Share Index (TASI) of the Saudi Exchange (Tadawul) would trade between 11,300 to 13,300 points (pts) in 2025, reflecting a …

Trading Activities

27 October 2024 00:40 PM Jamjoom Pharma posts SAR 305m net profits in 9M-24

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits valued at SAR 304.92 million in the first nine months (9M) of 2024, marking a 22.90% year-on-year (YoY) leap from SAR 247.92 million. The revenues hit …

Financial Results

7 August 2024 02:47 PM Jamjoom Pharma’s profits rise 23% in H1-24; dividends unveiled

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged net profits amounting to SAR 209.92 million in the first half (H1) of 2024, marking an annual plunge of 22.99% from SAR 170.67 million. The revenues hit SAR 731.20 …

Financial Results

8 July 2024 09:15 AM Jamjoom Pharma secures facility deal for unit in Algeria

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to support the issuance of a credit facility for its joint venture (JV) in Algeria, Jamjoom Algeria Lil Dawa SPA. A …

Companies Investments

5 June 2024 11:33 AM Jamjoom Pharma’s shareholders approve annual dividends for 2023

Riyadh – Mubasher: The extraordinary general meeting (EGM) of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) approved cash dividends amounting to SAR 105 million for the second half (H2) of 2023. The total dividends distributed and …

General Assembly

9 May 2024 00:08 PM Jamjoom Pharma registers SAR 103m net profits in Q1-24

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved 22% year-on-year (YoY) higher net profits at SAR 102.96 million in the first quarter (Q1) of 2024, versus SAR 84.40 million. Revenues amounted to SAR 385.46 …

Financial Results

4 April 2024 02:12 PM Jamjoom Pharma’s board proposes SAR 105m dividends

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recommended the distribution of SAR 105 million in cash dividends for 2023. The suggested dividends amount to SAR 1.50 per share to be distributed to 70 …

Cash Dividends

25 March 2024 00:32 PM Jamjoom Pharma posts 71% YoY higher profit in 2023

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged a 70.68% year-on-year (YoY) jump in net profit to SAR 292.40 million in 2023 from SAR 171.31 million. Revenues grew 20.09% YoY to SAR 1.10 billion last year from …

Financial Results

21 January 2024 04:05 PM Jamjoom Pharma secures funding to back JV in Algeria

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has secured a short-term revolving banking facility from the Bank of NATIXIS Algeria with a total amount of DZD 1.30 billion (SAR 36.20 million). The loan will support the …

Banking and Finance

22 November 2023 03:23 PM Saudi Jamjoom Pharma unveils financing for JV in Algeria

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to Al Salam Bank Algeria to back the issuance of a Shariah-compliant short-term revolving banking facility. The …

Companies Investments

7 November 2023 04:34 PM Jamjoom Pharma registers 77.5% leap in 9M-23 profits

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted an annual hike of 77.58% in net profit after Zakat and tax to SAR 247.90 million during the first nine months (9M) of 2023, versus SAR 139.60 million. The revenues …

Financial Results

13 August 2023 10:48 AM Jamjoom Pharma’s profit near SAR 171m in H1-23; dividends announced

Riyadh – Mubasher: The net profits after Zakat and tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) hiked by 81.59% to SAR 170.70 million in the first half (H1) of 2023, versus SAR 94 million in H1-22. Revenues stood at SAR 600.30 …

Financial Results

2 July 2023 03:21 PM Jamjoom Pharma records 94% higher net profit in Q1-23

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits worth SAR 84.40 million during the first quarter (Q1) of 2023, signalling a 94.02% surge from SAR 43.50 million in Q1-22. The earnings per share (EPS) …

Financial Results

19 June 2023 10:02 AM Jamjoom Pharma to begin Tadawul trading this week

Riyadh – Mubasher: The Saudi Exchange (Tadawul) announced that Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) will float its shares on the main market under the symbol 4015 on Tuesday, 20 June. In a bourse filing, Tadawul indicated that …

Trading Activities